Reinventing American Healthcare

Fortune
47 followers
Nov 16, 2026
Hi, everyone. How we doing? Good morning.
Mark, Zach, thank you so much for joining me.
Thanks for having us.
So great to be here.
Of course.
So I want to start with,
I feel like everyone in this room has complained about healthcare.
Everyone here is saying it needs to be reinvented.
But I think the problem is that almost every major player
in the system is currently benefiting
from it being so convoluted
and complex from drug companies, insurers, hospitals.
So what is one complexity that maybe
your own companies even benefit from that you think
It should be absolutely eliminated.
Eliminate employer-sponsored health insurance.
Tell me more.
So in the system today, you have 790,000 to 950,000,
depending on how you count them,
doctors who operate on a cash basis.
You have health care institutions that operate on a revenue basis.
You have everybody else that runs on a margin basis.
And you smash together all those economic models,
and it's a wonder it works at all.
But the second point is probably more important.
What's happened is because everybody has their own view
of how much they should make in that system,
all of those parties have competed over the years
to get their fair share of the pie
and have consolidated as a result.
So now we have major actors
who were an employer 15 years ago
with 20,000 or 30,000 employees
could get a great deal on a network,
can't because the networks are all consolidated.
And so they can't any longer use their economic power to buy properly.
So there's only one.
Americans always pick the best solution last.
That seems to be the trend.
That's the trend.
And so what we should do is we should let the consumer
with appropriate tools, which AI can now supply,
actually do their own shopping and making their own decisions.
Because when the consumers go into any market,
automobiles, hotels, travel.
They take the high rents out of the system almost immediately.
Yeah, that makes sense.
I want to come back to that.
But Zach, let's go to you first.
I would actually say the same exact answer.
I think that we talked about this backstage where
the customer in any industry, in our
mind, at least at Rowe and believe it, Oscar,
the customer is whoever controls the flow
of money at the point of purchase, right?
And most frequently in the healthcare system,
the patient is not the customer.
And so that creates like suboptimal outcomes just based on incentives.
And it's not that your employer doesn't care about you.
We both care a tremendous amount about our employees.
But the incentives are such that you have to care about many people.
over a shorter time horizon
and an individual cares about themselves and their family over
their entire life and so it's not like there's
that spider-man meme where everyone's sort of
pointing at each other and blaming themselves it's
not that any stakeholder in the health care
system is is evil it's just they're following the incentives at play
and in in our mind like
it's very similar to a form of government
and Americans choosing the last
option or the best option last, which is sort of democracy
is the worst form of government except for all of the rest.
In our mind, a patient is sort of the worst person
to determine their health care except for everyone else.
And people often talk about this asymmetry of information.
But as Mark talked about, I do believe with AI,
you're going to see that radically change.
You're already seeing a change, right?
300 million people every single month talk
to ChatGPT about their health.
It's giving pretty good answers.
There's a great article in the Wall Street Journal
this past weekend or late last week.
Thank
And so again, I think it just, again,
it always comes back to incentives and the more that you
empower a patient, the more that the system will bend
to the will of patients, which is ultimately
you
the outcome that we want.
Now, Mark, I want to come back to you because how far away do you think
very
we are from employer-sponsored plans being eliminated
and what do you think we need to do
to get there? 74% of all employers in the country,
much.
large employers, are considering
defined contribution for their employees.
And when we went to define contribution in the past pensions,
it took years for people
to figure it out because we gave them three options.
Everybody took the middle option,
which was I'll take the market basket, not the most
conservative, but we would all take in the aggressive one,
the portfolio, the equity
portfolio.
We all won big time over those years.
At least my pension would have been a lot better, my 401k.
But in the end, we didn't have any assistance.
We just threw the money at them and said, figure it out.
If we use the system
and technology to give them the tools to be able to find out where
is the best GLP-1 price I can get, I can get it delivered, bro.
And how do I get imaging instead of waiting two weeks
and worrying about what my mass
may be inside my breast?
How about tonight for $0
because we're buying excess capacity overnight and you can get
it?
But most consumers don't know that the first procedure
is $1,500 at the local hospital.
Which you pay a big piece of.
And the second one is zero dollars
because they're giving discounts
to have the capacity to use it in the nighttime shift.
So there are ways to do it,
but we have to build out the platform.
So if we get that information, curated pricing, I call it,
then there will be a tipping point.
It's starting with small employers.
They're just abandoning coverage right and left.
Then they're sending people to the ACA.
We have an AI population that is going to be impacted by AI,
people in the population affected by AI who are either going
to become part-time, multiple part-time jobs, or gig workers.
There's no solution for them, even
though the individual market would work for them if we built it right.
And then there are large employers who can no longer bargain,
who have large groups of part-time employees who they don't have
to give benefits to, who need health coverage as well.
I'm going to turn to the audience in one second for questions,
but I first want to ask Zach you a question,
and I see we have hands already up over there,
so back to you in one second, but Zach, you know,
Mark just teased a little bit about, you know, the cost of GLP-1s
and what you can offer on Rho, and I'm wondering if you can explain
to the audience a little bit more about how Rho works, because,
you know, from President Trump just rolled out Trump Rx, which
Kind of similar-ish, you've previously said you're supportive of it,
but Trump Rx, and I actually looked this up a couple days ago,
also lists, you know, the prices of a GLP-1 as the same on Rho.
So can you explain the differences?
And Rho, I know, is more of a membership.
How is that different, and what does the membership actually pay for?
Yeah, absolutely. So for us, our business model...
Patients pay us, and we deliver care and drugs, as Mark mentioned.
So our
smart, strong products, like that is the price of the drugs.
We support those prices.
The membership includes everything else
related to their care delivery, right?
So that's unlimited doctors,
back-and-forth conversations with patients.
That's lab testing.
That's one-to-one coaching.
That's side effect monitoring and dose titration.
So imagine that membership.
That's labs, their insurance concierge.
So that membership is basically all
the care delivery that someone would need.
For one low monthly price, in essence,
it's like consumer-based, value-based care, right?
They pay a fixed price, and they get an unlimited amount
of what they need, and then they get
the most affordable additional products,
so whether that's drugs, devices, additional
labs, supplements, things like that.
So that's the membership,
and then as far as Trump Rx and GLP-1s and what we've been
talking about here, I really do think GLP-1s
are this pretty incredible foil for the rest
of our healthcare system, because they've kind
of shed light on a lot of the flaws that
And we've also seen them very quickly through a consumer dynamic
and through that marketplace
course correct quite quickly, right?
So everyone has been talking about.
For the last 20, 25 years,
how do we have price transparency when it comes to drugs?
We have this constant list-to-net gap.
Well, what happened when pharma went direct?
That list-to-net gap just disappeared.
You had the net prices, and you've had two companies
constantly competing over unique business models,
unique form factors, differentiated pricing.
We worked with one of our pharma partners
to do something that is very commonplace in commerce,
But it was the first of its kind in consumer, which is...
offer patients discounts on their medication
when they committed to longer-term plans.
So patients on Rho can actually save between $600
and $1,800 a year on their medication.
That's a benefit of the membership where it
would actually pay for itself in that instance.
And do most users of it actually want to have it for that long?
Well, you actually see, so what's amazing
is we worked with one of our partners
to be able to have the patient where if they commit to a longer plan,
they save that money.
And if...
They need to stop medication at any point in time.
They pay what they would have paid monthly.
So they are no worse off.
It's not like they can't get that money back.
It's sort of like a discount option bet on their treatment.
But what it allows them to do is a pharma company,
for the first time ever,
is actually exchanging price for adherence,
knowing that these medications need to be used on a long-term basis.
What's this?
So you can take, by their going direct,
I think you can have very innovative business models.
Question in the back, over there.
Hi, Brent Foreman at the Charles Group NYC.
First up, just I think incredible on Oscar Health,
200% up in the last two years.
And, you know, just a lot of negative news,
but actually a lot of really good work.
I wanted to ask about what you think in terms of supplements,
compounding, and just in general,
the same way we've seen with driving,
you know, and people being able to say.
Hey, let me take this little driving test on my phone,
see how I do over 30 days, and
then you start getting a discount on driving.
First off, I don't think it's a deep enough discount to matter, right?
But I do think it's a huge difference,
and in America, we see a huge problem with people
eating how they want to eat,
which is not always the way you should eat, smoking, doing,
and I'm not against any of these things,
but I'm just saying, I think people who decide
not to take care of
premium for everyone, right? Because in other words, for themselves, right?
their health should
Not everyone needs to go to the doctor every single year with all
be paying a higher
of these things. There are some diseases that we can't control,
but I'm just interested to hear what you think about supplements,
you.
compounding, the advent of AI and how you think about being able
to help those who want to, you know, incur a higher risk.
Do they pay more or what do you think?
So, um.
Oscar is a cloud native platform,
the first new insurance platform since 1972.
We have one version of the truth in our data.
So we have been implementing AI at scale.
We have 40 large language models in the back of the business.
We have agents that are now coding.
67% of our coding is now done by coding agents.
We have a curse of conversations going on between our coding agents
and our platform models about
how to improve them on a daily basis in and out.
We've taken $1.2 billion out of our operating
infrastructure in the last three years,
a $4 million operating structure.
So the idea is that, first of all, affordability matters.
Second, people are buying supplements and other things
from compounding labs.
And I'll use my partner and I as an example.
She and I are on the Longevity Institute protocol
with hormone replacement, with supplements, the right diet.
We actually take human growth hormone precursors,
some oral, every evening, injections.
And we see a doctor
who titrates our body systems in a way that allow us
to do what I call square out the morbidity curve.
Instead of having a standard day in one to diapers and death,
how about you wake up on the morning of the day you
die completely capable, physical, and engaged.
You have a big breakfast dead by noon in the ground by five.
Which life do you want?
And most people want the second one, as long as it's long enough.
And the idea is that you need people on a constant program over time.
The way you get compliance is by having them work
with the same doctor or same institution
all the time.
And the way to do that is to take the financing
of our insurance away from the purchase of
insurance.
Create HSAs, HRA, kind of lookalike accounts,
bank accounts, wallets, if you will, and no matter
what your situation is, the money that you earn
for benefits goes into that wallet. You can keep
your doctor or your network. You can keep your plan design.
As a matter of fact, I would recommend
that we should have, and we're building this at Oscar,
lifestyle vignettes of your benefit plan
as you grow older. So we launched a product
this last year called Hello Menno for women going
I'm going through menopause.
Bone density scans, hormone replacement, behavioral counseling.
We're launching a new program for men.
Largely around suicide and the stresses of being a male in society.
So it's aimed at these populations.
So if you think about a lifestyle company
in concert with somebody like Roe,
building out this whole way of you living a better life as you go along
and not having it interrupted by changes
in your personal economic situation,
because you've got this bucket that can be funded by Medicaid,
ACA, Medicare, whatever,
and you get to buy what you want,
We're going to have a more.
You're gonna have a better experience. We're gonna have
a more economical system that can I come back to you?
And thank you Mark on the AI point
because I I am I'm how many people here have used
Either ChatGPT or Claude to diagnose
a health issue and it was right. I
I...
Got I got appendicitis in January and
Claude told me go to the hospital. You have appendicitis.
It's about to burst and it was true, but I am also so terrified of
All
Using AI to diagnose, to recommend drugs,
because I'm really scared about the incentives or what
it's pulling from. Can you talk to me about,
I know you just launched Robin AI, like how are
right.
you thinking about it going forward?
And should people be scared? There's sort of the macro
question around, I do think that consumer health will be the...
Uh, will be the use case that will change millions
or hundreds of millions of perception of AI,
because I actually think it's one
of the universal challenges that we all experience.
There's a massive shortage of care providers.
Um, and I think, you know, over 300 million people use,
use chat, uh, every single month for their health.
So I think it can be this place where people start
I'm starting to feel...
The magic of AI in a different way than they have previously
because right now people are just hearing about data centers
and people making trillions of dollars
and then they maybe have a like a slightly more expanded search.
And I'm obviously using those two extremes,
but that is creating a lot of tension.
What we did with Robin, and I love ChatGPT for Health,
have used it, but there's like
sort of two fundamental flaws in it in our mind
to really change a patient's health outcome.
The first is it takes a lot of time
and energy to give a context, right?
So you have to go and basically play the game of telephone.
What you told your doctor, what your doctor told you,
you have to then bring that back
to chat and you have to have a pretty good memory
and know exactly how to phrase it and
pull that in.
Um, and so that takes a lot of work and then you also have to have like
a PhD in prompting to really pull out the most useful thing.
So there's a tremendous amount of context on row.
We solved that problem by the very act
of your seeking out care with your doctor.
It is naturally building that context automatically.
When you share your family history, when you share a symptom,
when you log your weight, your dose, when you have a side effect,
when a doctor puts a note in your chart, whatever it may be,
your entire dose titration path for all the medications that you're on,
whatever that may be, it's already there.
So you're having incredibly rich conversations.
The second is when you go to chat,
let's say you come to the end of that conversation,
it goes, great, now you need to go talk to your doctor.
And for you, it was to go to the hospital.
You have to leave that environment,
and then you probably have to go do the same thing all over again,
but it can't take action, right?
For us, we actually take that insight,
and we can close that loop to intervention
and then have it tighter and tighter.
So when you're talking to Robin on Rho,
you could be having a conversation.
Maybe you're having a side effect.
Maybe you're interested in seeing if you should change your dose,
and it goes great.
I can actually, instead of saying,
go talk to your doctor, leave.
Here's a summary of that conversation,
press one button, it can be shared with your doctor.
That doctor can then review that summary,
your entire chats are private, but they can review
that summary as well as your whole health history.
Press a button and let's say you
needed a lower dose, it's on your doorstep 24 hours later.
So that's a pretty magical experience
that we think should be commonplace,
but it gets at, I think, the two fundamental flaws,
which is context and action, that typical chatbots have today.
I wish we had more time, but Mark,
I'm going to end on you with the last question,
because you have had such a long career in healthcare.
For those that don't know, Mark ran Aetna, sold it to CVS
in a $69 billion deal that was really, really big at the time, too.
But looking back now on that time period in your life,
because we've talked about how this system needs to be reinvented,
and you were a big player in that system for such a long time.
How do you look back on that period?
Do you think...
God, maybe I made this worse,
or how do you think about that from that point of view?
Well, to make an admission against self-interest,
I was actually part of the team that took Express
to this public back in 1994,
because we thought the PBM was a great idea.
I thought it would never last, but it did.
It was like five-card money on a street corner in New York.
Where's the queen?
I mean, and so,
I would say the intent of what happened between CVS and Aetna
was to create a new front door for health care where people could come
in and have a shopping experience in the front
of store instead of walking over all that dirty tile carpet
and hanging ceilings with old material on the shelves.
And that was our idea.
It never got pulled through because it took a lot of intensity.
To do it, I was moved to the board and the rules of CEO succession are,
you know, he who has the gold rules.
Um, number one, number two is there can only be one CEO
and rule number three is see rule number one.
Um, and so I was out and the real intention
and the purchasing organization was just to take the
earnings stream and revenue stream from that and to hide
a bunch of other things that they never
really fixed. There go the separation they're going through now.
And that now doesn't make
any sense as a strategy because of the pandemic
and virtual care and everything else that goes
You'd never do that deal now.
So, you know, I think, again, I'll say it, you know,
we try everything else until we get the right one,
which is the last one, and that's the consumer.
And I couldn't agree more with Zachary on this idea
that in the end analysis, if we give the right tools to consumers,
help them use it, moving them to the forefront to make their decisions
around health care, we'll end up being better for the American public.
Thank you so much. Thank you, Mark.
Thank you, Zach. Thank you all for listening.
We are now going to take a networking break.
And please join us back here at 1130
for a conversation on hypersonic warfare. Thank you.
